Medical Device | October 28, 2021
Thermo Fisher Scientific unveils Q Digital PCR system
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Key takeaways of recent quarter & conference call highlights
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
This strategic collaboration will enable continued innovation in cancer care
Following the pre-NDA meeting with the U.S. FDA, the companies confirmed the current efficacy and safety databases are expected to be adequate for filing with confirmed pathways for MDD and PPD
It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
Subscribe To Our Newsletter & Stay Updated
